Buscar resultados de ensayos clínicos
Paresis - 146 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Transcutaneous Electroacupuncture for Gastroparesis Condición: Diabetic Gastroparesis Fecha: 2011-11-08 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: A Pilot Study on the Efficacy and Safety of Olanzapine in Gastroparesis Condición: Idiopathic Gastroparesis Fecha: 2012-06-18 Intervenciones: Drug: Olanzapine Subjects will initially start on olanzapine 2.5 mg per mouth daily. Subjects will retur |
Terminated |
Nombre del estudio: Comparison of Two Macrolides, Azithromycin and Erythromycin, for Symptomatic Treatment of Gastroparesis Condición: Gastroparesis Fecha: 2011-03-24 Intervenciones:
|
Recruiting |
Nombre del estudio: Escalating Temporary Gastric Electrical Stimulation (GES) for Severe Gastroparesis Condición: Gastroparesis Fecha: 2014-06-06 |
Terminated |
Nombre del estudio: Diabetic Gastroparesis Efficacy/Safety Study of TZP-102 Condición: Diabetic Gastroparesis Fecha: 2012-08-10 Intervenciones:
|
Completed |
Nombre del estudio: MRI Brain Studies in Patients With HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis Condición: Tropical Spastic Paraparesis Fecha: 2002-05-01 |
Completed |
Nombre del estudio: Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) Condición: HTLV-I-Associated Myelopathy Fecha: 2011-04-25 Intervenciones: Drug: Tamibarotene Oral administration of tamibarotene 2 mg daily over a period of 12 weeks, then 4mg da |
Completed |
Nombre del estudio: Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) Condición: HTLV I Associated Myelopathy Fecha: 2008-10-15 Intervenciones: Drug: ciclosporin Ciclosporin 2.5 - 5mg/kg/day in two equally divided doses. dose adjusted according to |
Recruiting |
Nombre del estudio: Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Condición: HTLV-1 Fecha: 2006-07-12 Intervenciones: Drug: Hu MiK-Beta-1 |
Terminated |
Nombre del estudio: Safety and Efficiency Study of Valproic Acid In HAM/TSP Condición: HTLV-I-Associated Myelopathy Fecha: 2007-08-20 Intervenciones: Drug: Valproic Acid Valproic acid by oral route (20mg/Kg/day) during one year. |